S. Dhar

S. Dhar's recent work uses large-scale variant-effect experiments to study how mutations affect protein function relevant to human disease, including BRCA1 (a gene linked to breast and ovarian cancer risk) and TAP2 (a protein involved in presenting pieces of pathogens or tumor cells to the immune system). This research applies 'multiplexed assays of variant effect,' a technique that tests thousands of genetic variants simultaneously to determine which ones disrupt normal protein activity, such as DNA repair or immune antigen presentation.

Publication activity appears to have begun only in 2023 and 2024, with no recorded output in the preceding years of the last decade, suggesting a recent and still-emerging publication record rather than a long-established steady pattern.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026